Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.23.39 extracted from

  • Loesbanluechai, D.; Kotanan, N.; de Cozar, C.; Kochakarn, T.; Ansbro, M.R.; Chotivanich, K.; White, N.J.; Wilairat, P.; Lee, M.C.S.; Gamo, F.J.; Sanz, L.M.; Chookajorn, T.; Kuempornsin, K.
    Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine (2019), Int. J. Parasitol. Drugs Drug Resist., 9, 16-22 .
    View publication on PubMedView publication on EuropePMC
Search for more literature for 3.4.23.39

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
Hemoglobin + H2O Plasmodium falciparum
-
 ?
-
 ?

Organism

Organism UniProt Comment Textmining
Plasmodium falciparum Q8I6V3 isolate 3D7
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
Hemoglobin + H2O
-
 Plasmodium falciparum ?
-
 ?

General Information

General Information Comment Organism
physiological function enzyme overexpression fails to change the susceptibility of Plasmodium falciparum to artemisinin, chloroquine and piperaquine Plasmodium falciparum